SACRA Therapeutics mission is to innovate therapeutic strategies based on RNA epigenetics to treat incurable solid and hematological cancers.
SACRA Therapeutics represents a strategic collaborative research enterprise between Cristian Bellodi ‘s team at Lund University and Red Glead Discovery, built upon the original findings by the Bellodi group unravelling key roles for RNA modifications and protein biosynthesis in stem and cancer cells. SACRA Therapeutics addresses unmet clinical needs by developing lead compounds to target RNA modifiers in common tumor types characterized by metabolic dysfunction of protein synthesis and dismal prognosis.
https://sacratherapeutics.com/
SACRA Therapeutics represents a strategic collaborative research enterprise between Cristian Bellodi ‘s team at Lund University and Red Glead Discovery, built upon the original findings by the Bellodi group unravelling key roles for RNA modifications and protein biosynthesis in stem and cancer cells. SACRA Therapeutics addresses unmet clinical needs by developing lead compounds to target RNA modifiers in common tumor types characterized by metabolic dysfunction of protein synthesis and dismal prognosis.
https://sacratherapeutics.com/